SEER Inquiry System - Question 20041025 Details

System Guide

Back to Search Results

SEER Inquiry System - Report

Produced: 03/22/2026 1:13 PM

Question 20041025

Export CSV Export PDF Print

Add to Report

Inquiry Details

References:

#1: Micromedex. http://druginfo.cc.nih.gov

#2: 2004 SEER Manual, 189

Question:

Immunotherapy/Chemotherapy: Are monoclonal antibodies, such as Avastin and Erbitux, coded as immunotherapy or chemotherapy? See Discussion.

Discussion:

In review of the "FDA-approved oncology agents not listed in SEER Book 8" provided in 5/02, it appears "monoclonal antibodies" are coded as immunotherapy.

Answer:

Code Avastin and Erbitux as chemotherapy because both of these drugs are growth inhibitors. Code growth inhibitors (cytostatic agents) as chemotherapy. Do not assume that monoclonal antibodies are coded as immunotherapy.

Cancer Site Category:

N/A

Data Item Category:

Chemotherapy, First course treatment, Immunotherapy

Other Category:

N/A

Year:

2004